The firms aim to combine PerkinElmer 's Ordered Data Interpretation Network and FDNA's Face2Gene facial analysis software to target emerging markets.
New funding will support assay development and lab space to offer test services, and ultimately a test kit using the firm's resistance database.
By leveraging HealthShare's Informatic Exchange solution, Rhodes Group will create a longitudinal, standardized data repository across TriCore's laboratories.
The agency finalized recommendations for developing and validating NGS tests, and proposed a submission process for investigational IVDs in cancer Rx trials.
The collaboration will use AI to determine if patients can be grouped based on diagnostic test information, potentially leading to quicker and better diagnoses and treatments.
Centogene opened a Boston office in December and plans to open a lab there in a few months as it awaits an FDA decision on its clinical tool.
The clinicals labs contributing to the database are adding more case-level data and focusing on outlier interpretations.
CureOne also received CMS's approval for 11 quality metrics around biomarker testing that doctors can report for MIPS-related payment.
Payors' demands for clinical utility evidence can be met through greater use of databases and registries, Harold Varmus and Rebecca Eisenberg said.
The addition of the patient-facing family history platform will expand and enhance Invitae's existing genome management support services, the company said.